Keywords
Last Name

Harold Wanebo, MD

TitleEmeritus Professor
InstitutionBoston University School of Medicine
DepartmentSurgery
DivisionSurgical Oncology
Address25 Buick St
Boston MA
Other Positions
InstitutionRoger Williams Medical Center

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Stephen AH, Fallon EA, Kalife E, Wanebo H. Radiation-associated sarcoma after recurrent colorectal primary tumor: A complex surgical case. J Surg Oncol. 2015 Nov; 112(6):658-61. PMID: 26430853.
    View in: PubMed
  2. Wanebo HJ, Lee J, Burtness BA, Ridge JA, Ghebremichael M, Spencer SA, Psyrri D, Pectasides E, Rimm D, Rosen FR, Hancock MR, Tolba KA, Forastiere AA. Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303). Ann Oncol. 2014 Oct; 25(10):2036-41. PMID: 25009013.
    View in: PubMed
  3. Psyrri A, Lee JW, Pectasides E, Vassilakopoulou M, Kosmidis EK, Burtness BA, Rimm DL, Wanebo HJ, Forastiere AA. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303. Clin Cancer Res. 2014 Jun 1; 20(11):3023-32. PMID: 24700741.
    View in: PubMed
  4. Best C, Calianese D, Szulak K, Cammarata G, Brum G, Carbone T, Still E, Higgins K, Ji F, DI W, Wanebo H, Wan Y. Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death. Oncol Lett. 2013 Jun; 5(6):1854-1858. PMID: 23833655.
    View in: PubMed
  5. Wu CH, Cao C, Kim JH, Hsu CH, Wanebo HJ, Bowen WD, Xu J, Marshall J. Trojan-horse nanotube on-command intracellular drug delivery. Nano Lett. 2012 Nov 14; 12(11):5475-80. PMID: 23030797.
    View in: PubMed
  6. Wanebo HJ, LeGolvan M, Paty PB, Saha S, Zuber M, D'Angelica MI, Kemeny NE. Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis. 2012 Oct; 29(7):821-39. PMID: 23053740.
    View in: PubMed
  7. Karakousis CP, Wanebo H. Pelvic surgery. Int J Surg Oncol. 2012; 2012:287096. PMID: 23029608.
    View in: PubMed
  8. Ready NE, Rathore R, Johnson TT, Nadeem A, Chougule P, Ruhl C, Radie-Keane K, Theall K, Wanebo HJ, Marcello J, Kennedy T. Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2012 Feb; 35(1):6-12. PMID: 21293244.
    View in: PubMed
  9. White RL, Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ, Avisar E, Hauschild A, Egberts F, Averbook BJ, Garberoglio CA, Vetto JT, Ross MI, Chu D, Trisal V, Hoekstra H, Whitman E, Wanebo HJ, Debonis D, Vezeridis M, Chevinsky A, Kashani-Sabet M, Shyr Y, Berry L, Zhao Z, Soong SJ, Leong SP. Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol. 2011 Dec; 18(13):3593-600. PMID: 21647761.
    View in: PubMed
  10. Cong C, Lu S, Shrayer D, Wanebo HJ, Wan Y, Bowen W. The effect of blocking the prosurvival AKT/P13K/mTOR and mutant KRAS-signaling pathways on chemotherapy resistance of pancreatic cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):e13514. PMID: 28022938.
    View in: PubMed
  11. Wanebo HJ, Sanikommu SR, Taneja C, Begossi G, Cummings FJ, Belliveau J. Hepatic artery infusion for recurrent or chemotherapy-resistant hepatic malignancy. J Clin Oncol. 2011 May 20; 29(15_suppl):e14151. PMID: 28023237.
    View in: PubMed
  12. Psyrri A, Ghebremichael MS, Pectasides E, Dimou AT, Burtness B, Rimm D, Wanebo HJ, Forastiere AA. p16 protein status and response to treatment in a prospective clinical trial (ECOG 2303) of patients with head and neck squamous cell carcinoma (HNSCC). J Clin Oncol. 2011 May 20; 29(15_suppl):e16032. PMID: 28023645.
    View in: PubMed
  13. Wanebo HJ, Rathore R, Chougule P, DiSiena MR, Koness RJ, McRae RG, Nigri PT, Radie-Keane K, Ready N. Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies. Ann Surg Oncol. 2011 Nov; 18(12):3479-85. PMID: 21553142.
    View in: PubMed
  14. Berz D, Wanebo H. Targeting the growth factors and angiogenesis pathways: small molecules in solid tumors. J Surg Oncol. 2011 May 1; 103(6):574-86. PMID: 21480252.
    View in: PubMed
  15. Wanebo HJ, Reddy Sanikommu S, Padmaja V, Taneja C, Cummings FJ, Begossi G, Belliveau J. Hepatic artery infusion for recurrent or chemoresistant hepatic malignancy. J Clin Oncol. 2011 Feb; 29(4_suppl):351. PMID: 27985438.
    View in: PubMed
  16. Wanebo H. Biologic and surgical challenge of colorectal hepatic metastases. Dedication to Dr. Leslie Blumgart and Dr. Henri Bismuth. J Surg Oncol. 2010 Dec 15; 102(8):889-90. PMID: 21165989.
    View in: PubMed
  17. Wanebo HJ, Berz D. The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors. J Surg Oncol. 2010 Dec 15; 102(8):891-7. PMID: 21165990.
    View in: PubMed
  18. Wanebo H. Role of biologic therapy in surgical management of hepatic metastases. J Surg Oncol. 2010 Dec 1; 102(7):715-6. PMID: 21104920.
    View in: PubMed
  19. Varker KA, Wanebo HJ. Salvage of pelvic recurrence of colorectal cancer. J Surg Oncol. 2010 Jun 15; 101(8):649-60. PMID: 20512940.
    View in: PubMed
  20. Wanebo HJ, Begossi G, Belliveau J, Gustafson E. Isolated chemotherapeutic perfusion as neoadjuvant therapy for advanced/unresectable pelvic malignancy. J Clin Oncol. 2009 May 20; 27(15_suppl):2555. PMID: 27961873.
    View in: PubMed
  21. Nadeem A, Wanebo H, Shrayer D, Hazelwood S, Resnick M. Effect of the apoptosis signal ceramide (C6) on antitumor activity of chemotherapeutic agents in SCID mice. J Clin Oncol. 2009 May 20; 27(15_suppl):e14642. PMID: 27964231.
    View in: PubMed
  22. Begossi G, Belliveau JF, Wanebo HJ. Pelvic perfusion for advanced colorectal cancers. Surg Oncol Clin N Am. 2008 Oct; 17(4):825-42, ix-x. PMID: 18722921.
    View in: PubMed
  23. Wanebo HJ. Preface. The evolution of regional therapy modalities. Surg Oncol Clin N Am. 2008 Oct; 17(4):xvii-xix. PMID: 18722913.
    View in: PubMed
  24. Muchmore JH, Wanebo HJ. Regional chemotherapy: overview. Surg Oncol Clin N Am. 2008 Oct; 17(4):709-30, vii. PMID: 18722914.
    View in: PubMed
  25. Belliveau JF, Wanebo HJ. Clinical pharmacokinetics of isolated pelvic perfusion. Surg Oncol Clin N Am. 2008 Oct; 17(4):773-84, viii. PMID: 18722917.
    View in: PubMed
  26. Wanebo HJ. Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchronous bilateral mastectomies (Chen et al.). J Surg Oncol. 2008 Sep 1; 98(3):147. PMID: 18704913.
    View in: PubMed
  27. Cummings FJ, Varker K, Begossi G, Taneja C, Wanebo HJ. Hepatic artery infusion in surgical therapy of hepatic metastases from colorectal cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):15077. PMID: 27950334.
    View in: PubMed
  28. Wanebo HJ, Rathore R, Radie-Keane K, Ready N, Nadeem A, Nigri P, Chougule P. Use of restaging primary site biopsy to optimize selection of primary therapy in high stage (III/IV) squamous cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6042. PMID: 27950543.
    View in: PubMed
  29. Chougule PB, Akhtar MS, Rathore R, Koness J, McRae R, Nigri P, Radie-Keane K, Kennedy T, Wanebo HJ, Ready N. Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53). Head Neck. 2008 Mar; 30(3):289-96. PMID: 17657799.
    View in: PubMed
  30. Wanebo HJ, DiSiena M, Begossi G, Belliveau J, Gustafson E. Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum. Ann Surg Oncol. 2008 Apr; 15(4):1107-16. PMID: 18157578.
    View in: PubMed
  31. Safran H, Suntharalingam M, Dipetrillo T, Ng T, Doyle LA, Krasna M, Plette A, Evans D, Wanebo H, Akerman P, Spector J, Kennedy N, Kennedy T. Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):391-5. PMID: 17980508.
    View in: PubMed
  32. Wanebo HJ, Berz D, Mega A. Targeting small molecules in cancer. Cancer Treat Res. 2007; 135:239-55. PMID: 17953421.
    View in: PubMed
  33. Qiu L, Zhou C, Sun Y, Di W, Scheffler E, Healey S, Wanebo H, Kouttab N, Chu W, Wan Y. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. Oncol Rep. 2006 Oct; 16(4):907-13. PMID: 16969513.
    View in: PubMed
  34. Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Int J Oncol. 2006 Jul; 29(1):269-78. PMID: 16773209.
    View in: PubMed
  35. Rathore R, Iannitti D, Soares G, Wanebo H, Maia-Aucna C, Safran H. Hepatic arterial infusion (HAI) of oxaliplatin in advanced hepatocellular cancer (HCC): A phase I study. J Clin Oncol. 2006 Jun 20; 24(18_suppl):14010. PMID: 27952366.
    View in: PubMed
  36. Suntharalingam M, Dipetrillo T, Akerman P, Wanebo H, Daly B, Doyle LA, Krasna MJ, Kennedy T, Safran H. Cetuximab, paclitaxel, carboplatin and radiation for esophageal and gastric cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4029. PMID: 27953715.
    View in: PubMed
  37. Wanebo HJ, Frackelton AR, Hafer LJ, Bagdasaryan R, Lis R, Sabo E, Resnick MB. Shc test as a strong prognostic indicator of disease outcome in early stage gastric cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10090. PMID: 27954030.
    View in: PubMed
  38. Shrayer D, Wanebo HJ, Resnick M. Apoptosis signal ceramide c6 synergizes anti-tumor effects of paclitaxel oxaliplatin & cisplatin on growth of pancreatic cancer in SCID mice. J Clin Oncol. 2006 Jun 20; 24(18_suppl):13135. PMID: 27954081.
    View in: PubMed
  39. Taneja C, Somasundar P, Stager S, Carroll E, Wanebo HJ, Radie-Keane K, Nadeem O. Although substantial (qol) quality of life problems may occur due to acute and delayed complications of therapy for advanced head & neck squamous cancer, overall long term qol is good/acceptable. J Clin Oncol. 2006 Jun 20; 24(18_suppl):15510. PMID: 27955272.
    View in: PubMed
  40. Wanebo HJ, Argiris A, Bergsland E, Agarwala S, Rugo H. Targeting growth factors and angiogenesis; using small molecules in malignancy. Cancer Metastasis Rev. 2006 Jun; 25(2):279-92. PMID: 16770540.
    View in: PubMed
  41. Leong SP, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL, Chu D, Biel M, Charney K, Wanebo H, Avisar E, Vetto J, Soong SJ. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg. 2006 Apr; 132(4):370-3. PMID: 16618904.
    View in: PubMed
  42. Qiu L, Di W, Jiang Q, Scheffler E, Derby S, Yang J, Kouttab N, Wanebo H, Yan B, Wan Y. Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death. Int J Oncol. 2005 Nov; 27(5):1441-8. PMID: 16211241.
    View in: PubMed
  43. Ready N, Aronson F, Wanebo H, Kennedy T. A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma. Am J Clin Oncol. 2005 Oct; 28(5):479-84. PMID: 16199988.
    View in: PubMed
  44. Qiu L, Wang Q, Di W, Jiang Q, Schefeller E, Derby S, Wanebo H, Yan B, Wan Y. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Int J Oncol. 2005 Sep; 27(3):823-30. PMID: 16077934.
    View in: PubMed
  45. DiSiena MR, Taneja C, Wanebo HJ. Radical gastrectomy and lymphadenectomy: historic overview, surgical trends, and lessons from the past. Surg Oncol Clin N Am. 2005 Jul; 14(3):511-32, vi-vii. PMID: 15978427.
    View in: PubMed
  46. Wanebo HJ, Begossi G, Ponomarenko I. Aggressive regional therapy vs conventional treatment of patients with unresected liver metastases from colorectal cancer: A multivariate analysis focused on overall survival. J Clin Oncol. 2005 Jun; 23(16_suppl):3675. PMID: 27944916.
    View in: PubMed
  47. Rathore R, Chougule P, Wanebo H, Theall K, Ruhl C, Nadeem A, Koness J, Oldenburg N, Kennedy T, Ready N. Phase II study of induction weekly paclitaxel, ifosfamide, and carboplatin (PIC) followed by chemoradiotherapy (CRT) in locally advanced head and neck squamous cell cancer (HNSCC): A Brown University Oncology Group study (HN-86). J Clin Oncol. 2005 Jun; 23(16_suppl):5556. PMID: 27945323.
    View in: PubMed
  48. Hundahl SA, Wanebo HJ. Changing gastric cancer treatment in the United States and the pursuit of quality. Eur J Surg Oncol. 2005 Aug; 31(6):605-15. PMID: 16023944.
    View in: PubMed
  49. Wanebo HJ, Begossi G, Varker KA. Surgical management of pelvic malignancy: role of extended abdominoperineal resection/exenteration/abdominal sacral resection. Surg Oncol Clin N Am. 2005 Apr; 14(2):197-224. PMID: 15817235.
    View in: PubMed
  50. Belliveau JF, Arevalo E, Griffin H, Wanebo HJ. Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug. Cancer Chemother Pharmacol. 2005 Apr; 55(4):318-22. PMID: 15654643.
    View in: PubMed
  51. Gervasoni JE, Hindenburg AA, Vezeridis MP, Schulze S, Wanebo HJ, Mehta S. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis. Anticancer Res. 2004 Sep-Oct; 24(5A):2617-26. PMID: 15517865.
    View in: PubMed
  52. Nadeem A, Desai S, Chougule P, Wanebo H, Ruhl C, Joyce D, Tarro J, Kennedy T, Ready N. Decreased distant recurrence and preserved local control using dose dense induction weekly paclitaxel (P) and carboplatin (C) followed by concurrent paclitaxel, carboplatin and radiotherapy (CRT) in locally advanced head and neck squamous cell cancers (HN-SCC). J Clin Oncol. 2004 Jul 15; 22(14_suppl):5545. PMID: 28013985.
    View in: PubMed
  53. Wanebo HJ, Chougule P, Ready N, Koness RJ, McRae R, Nigri P, Radie-Keane K, Rathore R, Kennedy T. Preoperative chemoradiation directed by primary site rebiopsy in stage III/IV squamous head and neck cancer is associated with high rate of local regional control, but is still plagued by long-term distant failure. J Clin Oncol. 2004 Jul 15; 22(14_suppl):5549. PMID: 28013988.
    View in: PubMed
  54. Begossi G, Disiena M, Wrobleski D, Vezeridis M, Allen H, Wanebo HJ. Potential for surgical salvage of recurrent rectal cancer is governed by patterns of recurrence and ability to achieve an R0 resection. J Clin Oncol. 2004 Jul 15; 22(14_suppl):3759. PMID: 28014091.
    View in: PubMed
  55. Rathore R, Chougule P, Wanebo H, Nadeem A, Radie-Keane K, Sikov W, Negri P, Kennedy T, Ready N. Phase I/II study of induction weekly paclitaxel, ifosfamide and carboplatin (PIC) followed by chemoradiotherapy (CRT) in advanced head and neck squamous cell cancers (HN-SCC). J Clin Oncol. 2004 Jul 15; 22(14_suppl):5602. PMID: 28015291.
    View in: PubMed
  56. Chauhan B, Wanebo H, Rathore R, Chougule P, Kennedy T, Ready N. Phase I /II study of carboplatin with weekly ifosfamide and docetaxel in recurrent or metastatic head and neck squamous cell cancers (HN-SCC). J Clin Oncol. 2004 Jul 15; 22(14_suppl):5601. PMID: 28015293.
    View in: PubMed
  57. Shrayer D, Essis D, Mehta S, Wanebo H. Ceramide, a mediator of apoptosis, synergizes with paclitaxel to induce regression of the L3.6 human pancreatic carcinoma implanted in SCID mice. J Clin Oncol. 2004 Jul 15; 22(14_suppl):2135. PMID: 28016899.
    View in: PubMed
  58. de Aretxabala XA, Roa IS, Mora JP, Orellana JJ, Riedeman JP, Burgos LA, Silva VP, Cuadra AJ, Wanebo HJ. Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer. World J Surg. 2004 Jun; 28(6):544-7. PMID: 15366742.
    View in: PubMed
  59. Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W, Safran H, Wanebo HJ. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004 Feb; 27(1):51-6. PMID: 14758134.
    View in: PubMed
  60. Safran H, DiPetrillo T, Nadeem A, Steinhoff M, Tantravahi U, Rathore R, Wanebo H, Hughes M, Maia C, Tsai JY, Pasquariello T, Pepperell JR, Cioffi W, Kennedy T, Reeder L, Ng T, Adrian A, Goldstein L, Chak B, Choy H. Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study. Cancer Invest. 2004; 22(5):670-7. PMID: 15581047.
    View in: PubMed
  61. Wanebo HJ, Belliveau J, Begossi G, Levy A. Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer. Colorectal Dis. 2003 Sep; 5(5):508-14. PMID: 12925091.
    View in: PubMed
  62. Delaney M, Stancu M, Begossi G, Elfenbein GJ, Wanebo HJ. Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow stem cell support for advanced endometrial cancer. Med Health R I. 2003 Aug; 86(8):252-5. PMID: 14582223.
    View in: PubMed
  63. Gervasoni JE, Wanebo HJ. Cancers of the anal canal and anal margin. Cancer Invest. 2003 Jun; 21(3):452-64. PMID: 12901291.
    View in: PubMed
  64. Tomicic J, Wanebo HJ. Mucosal melanomas. Surg Clin North Am. 2003 Apr; 83(2):237-52. PMID: 12744608.
    View in: PubMed
  65. Taneja C, Allen H, Koness RJ, Radie-Keane K, Wanebo HJ. Changing patterns of failure of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002 Mar; 128(3):324-7. PMID: 11886352.
    View in: PubMed
  66. Shrayer DP, Bogaars H, Cole B, Wolf SF, Wanebo HJ. Capacity of murine IL-12 to inhibit the development of primary melanoma tumors and to prevent lung metastases in the melanoma-challenged mice. J Exp Ther Oncol. 2002 Mar-Apr; 2(2):93-9. PMID: 12415625.
    View in: PubMed
  67. Schrayer DP, Kouttab N, Hearing VJ, Wanebo HJ. Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A. Clin Exp Metastasis. 2002; 19(1):43-53. PMID: 11918082.
    View in: PubMed
  68. Wanebo H, Chougule P, Ready N, Safran H, Ackerley W, Koness RJ, McRae R, Nigri P, Leone L, Radie-Keane K, Reiss P, Kennedy T. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol. 2001 Sep; 8(8):644-50. PMID: 11569779.
    View in: PubMed
  69. Wanebo HJ. Pelvic soft tissue sarcomas present a challenge to therapists. J Surg Oncol. 2001 Jun; 77(2):79-80. PMID: 11398157.
    View in: PubMed
  70. Safran H, Moore T, Iannitti D, Dipetrillo T, Akerman P, Cioffi W, Harrington D, Quirk D, Rathore R, Cruff D, Vakharia J, Vora S, Savarese D, Wanebo H. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2001 Apr 1; 49(5):1275-9. PMID: 11286834.
    View in: PubMed
  71. Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Desmond R. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol. 2001 Mar; 8(2):101-8. PMID: 11258773.
    View in: PubMed
  72. Avradopolous K, Wanebo HJ, Pappas SG. Resection for recurrent colorectal liver metastases. Cancer Treat Res. 2001; 109:219-27. PMID: 11775438.
    View in: PubMed
  73. Safran H, Gaissert H, Akerman P, Hesketh PJ, Chen MH, Moore T, Koness J, Graziano S, Wanebo HJ. Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer Invest. 2001; 19(1):1-7. PMID: 11291548.
    View in: PubMed
  74. Wanebo HJ. The challenge of early gastric cancer: the need to optimize microstaging and therapy. Gastric Cancer. 2000 Dec 27; 3(3):121-122. PMID: 11984723.
    View in: PubMed
  75. Corsetti RL, Allen HM, Wanebo HJ. Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol. 2000 Jul; 7(6):456-60. PMID: 10894142.
    View in: PubMed
  76. Safran H, Wanebo HJ, Hesketh PJ, Akerman P, Ianitti D, Cioffi W, DiPetrillo T, Wolf B, Koness J, McAnaw R, Moore T, Chen MH, Radie-Keane K. Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys. 2000 Mar 1; 46(4):889-94. PMID: 10705010.
    View in: PubMed
  77. Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Harrison R. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000 Mar; 7(2):87-97. PMID: 10761786.
    View in: PubMed
  78. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg. 2000 Jan; 135(1):81-7; discussion 88. PMID: 10636353.
    View in: PubMed
  79. Mehta S, Blackinton D, Omar I, Kouttab N, Myrick D, Klostergaard J, Wanebo H. Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother Pharmacol. 2000; 46(2):85-92. PMID: 10972477.
    View in: PubMed
  80. Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum. 1999 Nov; 42(11):1438-48. PMID: 10566532.
    View in: PubMed
  81. Myrick D, Blackinton D, Klostergaard J, Kouttab N, Maizel A, Wanebo H, Mehta S. Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. Leuk Res. 1999 Jun; 23(6):569-78. PMID: 10374850.
    View in: PubMed
  82. Hofer SO, Molema G, Hermens RA, Wanebo HJ, Reichner JS, Hoekstra HJ. The effect of surgical wounding on tumour development. Eur J Surg Oncol. 1999 Jun; 25(3):231-43. PMID: 10336800.
    View in: PubMed
  83. Meneu JC, Wanebo HJ, Nistal JA. [Abdominosacral resection for locoregional recurrence rectal cancer]. Rev Esp Enferm Dig. 1999 May; 91(5):374-9. PMID: 10362879.
    View in: PubMed
  84. Chougule PB, Akhtar MS, Akerley W, Ready N, Safran H, McRae R, Nigri P, Bellino J, Koness J, Radie-Keane K, Wanebo H. Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study. Semin Radiat Oncol. 1999 Apr; 9(2 Suppl 1):58-63. PMID: 10210541.
    View in: PubMed
  85. Safran H, Akerman P, Cioffi W, Gaissert H, Joseph P, King T, Hesketh PJ, Wanebo H. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. Semin Radiat Oncol. 1999 Apr; 9(2 Suppl 1):53-7. PMID: 10210540.
    View in: PubMed
  86. Wanebo HJ, Chougule P, Ready N, Koness RJ, Akerley W, McRae R, Nigri P, Leone L, Webber B, Safran H. Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV). Semin Radiat Oncol. 1999 Apr; 9(2 Suppl 1):77-84. PMID: 10210544.
    View in: PubMed
  87. Shrayer DP, Cole B, Hearing VJ, Wolf SF, Wanebo HJ. Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12. Clin Exp Metastasis. 1999 Feb; 17(1):63-70. PMID: 10390149.
    View in: PubMed
  88. Wanebo HJ, Belliveau JF. A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol. 1999; 43(5):427-34. PMID: 10100600.
    View in: PubMed
  89. Heywood G, Vezeridis MP, Wanebo HJ. Surgical therapy of pancreatic cancer. Front Biosci. 1998 Nov 1; 3:E175-80. PMID: 9792897.
    View in: PubMed
  90. Shrayer DP, Bogaars H, Wolf SF, Hearing VJ, Wanebo HJ. A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Int J Oncol. 1998 Aug; 13(2):361-74. PMID: 9664134.
    View in: PubMed
  91. Wanebo H, Coburn M, Teates D, Cole B. Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg. 1998 Jun; 227(6):912-21. PMID: 9637555.
    View in: PubMed
  92. Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. Prognostic analysis of survival in small breast cancers. J Am Coll Surg. 1998 May; 186(5):562-9. PMID: 9583697.
    View in: PubMed
  93. Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg. 1998 Apr; 133(4):383-9. PMID: 9565118.
    View in: PubMed
  94. Konstadoulakis MM, Vezeridis M, Hatziyianni E, Karakousis CP, Cole B, Bland KI, Wanebo HJ. Molecular oncogene markers and their significance in cutaneous malignant melanoma. Ann Surg Oncol. 1998 Apr-May; 5(3):253-60. PMID: 9607628.
    View in: PubMed
  95. Shrayer DP, Kouttab N, Hearing VJ, Wanebo HJ. Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A. Cancer Immunol Immunother. 1998 Mar; 46(1):7-13. PMID: 9520286.
    View in: PubMed
  96. Wanebo HJ. Surgical quality control - A Herculean task not easily achieved The Dutch gastric trial as a primer. Gastric Cancer. 1998 Mar; 1(2):93-94. PMID: 11957051.
    View in: PubMed
  97. Amato SF, Swart JM, Berg M, Wanebo HJ, Mehta SR, Chiles TC. Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res. 1998 Jan 15; 58(2):241-7. PMID: 9443400.
    View in: PubMed
  98. Chougule P, Wanebo H, Akerley W, McRae R, Nigri P, Leone L, Safran H, Ready N, Koness RJ, Radie-Keane K, Cole B. Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-57-S19-61. PMID: 9427268.
    View in: PubMed
  99. Koness RJ, Glicksman A, Liu L, Coachman N, Landman C, Slotman G, Wanebo HJ. Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients. Am J Surg. 1997 Nov; 174(5):532-5. PMID: 9374231.
    View in: PubMed
  100. Wanebo HJ, Chougule P, Akerley WL, Koness RJ, McRae R, Nigri P, Leone L, Ready N, Safran H, Webber B, Cole B. Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. Am J Surg. 1997 Nov; 174(5):518-22. PMID: 9374228.
    View in: PubMed
  101. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997 Oct-Nov; 4(7):545-50. PMID: 9367019.
    View in: PubMed
  102. Glicksman AS, Wanebo HJ, Slotman G, Liu L, Landmann C, Clark J, Zhu TC, Lohri A, Probst R. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1997 Oct 1; 39(3):721-9. PMID: 9336155.
    View in: PubMed
  103. Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg. 1997 Aug; 185(2):177-84. PMID: 9249086.
    View in: PubMed
  104. Mehta S, Blackinton D, Manfredi M, Rajaratnam D, Kouttab N, Wanebo H. Taxol pretreatment of tumor targets amplifies natural killer cell mediated lysis. Leuk Lymphoma. 1997 Jun; 26(1-2):67-76. PMID: 9250789.
    View in: PubMed
  105. Wanebo HJ, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, Bland K. Is surgical management compromised in elderly patients with breast cancer? Ann Surg. 1997 May; 225(5):579-86; discussion 586-9. PMID: 9193185.
    View in: PubMed
  106. Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg. 1997 Apr; 132(4):384-90; discussion 390-1. PMID: 9108759.
    View in: PubMed
  107. Chu QD, Vezeridis MP, Avradopoulos KA, Wanebo HJ. Repeat hepatic resection for recurrent colorectal cancer. World J Surg. 1997 Mar-Apr; 21(3):292-6. PMID: 9015173.
    View in: PubMed
  108. Safran H, King TP, Choy H, Hesketh PJ, Wolf B, Altenhein E, Sikov W, Rosmarin A, Akerley W, Radie-Keane K, Cicchetti G, Lopez F, Bland K, Wanebo HJ. Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. J Clin Oncol. 1997 Mar; 15(3):901-7. PMID: 9060526.
    View in: PubMed
  109. Avradopoulos K, Mehta S, Blackinton D, Wanebo HJ. Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol. 1997 Mar; 4(2):184-90. PMID: 9084857.
    View in: PubMed
  110. Avradopoulos DA, Vezeridis MP, Wanebo HJ. Soft tissue sarcoma. Med Health R I. 1997 Jan; 80(1):15-8. PMID: 9009578.
    View in: PubMed
  111. Wanebo HJ. Sarcoma: a challenging frontier for the oncologist. Med Health R I. 1997 Jan; 80(1):5-7. PMID: 9009576.
    View in: PubMed
  112. Wanebo HJ. Head and neck sarcoma. Med Health R I. 1997 Jan; 80(1):26-30. PMID: 9009580.
    View in: PubMed
  113. White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg. 1996 Dec; 183(6):575-82. PMID: 8957459.
    View in: PubMed
  114. Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg. 1996 Dec; 183(6):616-24. PMID: 8957465.
    View in: PubMed
  115. Chung MA, Wanebo HJ. Surgical management and treatment of gastric and duodenal fistulas. Surg Clin North Am. 1996 Oct; 76(5):1137-46. PMID: 8841368.
    View in: PubMed
  116. Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Ross MI, Jewell WR, Mihm MC, Barnhill RL, Wanebo HJ. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996 Sep; 224(3):255-63; discussion 263-6. PMID: 8813254.
    View in: PubMed
  117. Clark JW, Glicksman AS, Wanebo HJ. Systemic and adjuvant therapy for patients with pancreatic carcinoma. Cancer. 1996 Aug 1; 78(3 Suppl):688-93. PMID: 8681308.
    View in: PubMed
  118. Rothenberg ML, Abbruzzese JL, Moore M, Portenoy RK, Robertson JM, Wanebo HJ. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer. 1996 Aug 1; 78(3 Suppl):627-32. PMID: 8681301.
    View in: PubMed
  119. Wanebo HJ, Vezeridis MP. Pancreatic carcinoma in perspective. A continuing challenge. Cancer. 1996 Aug 1; 78(3 Suppl):580-91. PMID: 8681296.
    View in: PubMed
  120. Shrayer D, Park C, Kouttab N, Bogaars H, McInnis R, Paul S, Maizel A, Hearing V, Wanebo H. Intrasplenic vaccination against experimental melanoma. Int J Oncol. 1996 Jul; 9(1):123-9. PMID: 21541491.
    View in: PubMed
  121. Ohta T, Fukuda M, Wanebo HJ, Jogo K, Yamaguchi S. Behavior of the cell cycle-associated proteins in an unusual G0-arrestable cancer cell line. Exp Cell Res. 1996 May 25; 225(1):85-92. PMID: 8635520.
    View in: PubMed
  122. Wanebo HJ, Chung MA, Levy AI, Turk PS, Vezeridis MP, Belliveau JF. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique. Ann Surg Oncol. 1996 May; 3(3):295-303. PMID: 8726186.
    View in: PubMed
  123. Wanebo HJ, Chu QD, Avradopoulos KA, Vezeridis MP. Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery. 1996 Apr; 119(4):361-71. PMID: 8643998.
    View in: PubMed
  124. Koness RJ, King TC, Schechter S, McLean SF, Lodowsky C, Wanebo HJ. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity. Ann Surg Oncol. 1996 Mar; 3(2):136-43. PMID: 8646513.
    View in: PubMed
  125. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg. 1996 Mar; 131(3):322-9. PMID: 8611099.
    View in: PubMed
  126. Shrayer DP, Bogaars H, Hearing VJ, Wanebo HJ. Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy. J Exp Ther Oncol. 1996 Mar; 1(2):126-33. PMID: 9414396.
    View in: PubMed
  127. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996 Jan 1; 77(1):97-103. PMID: 8630946.
    View in: PubMed
  128. Avradopoulos KA, Vezeridis MP, Wanebo HJ. Pelvic exenteration for recurrent rectal cancer. Adv Surg. 1996; 29:215-33. PMID: 8720005.
    View in: PubMed
  129. Clark J, Sikov W, Cummings F, Browne M, Akerley W, Wanebo H, Weitberg A, Kennedy T, Cole B, Bigley J, Beitz J, Darnowski J. Phase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancer. J Cancer Res Clin Oncol. 1996; 122(9):554-8. PMID: 8781570.
    View in: PubMed
  130. Coburn MC, Wanebo HJ. Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg. 1995 Nov; 170(5):471-5. PMID: 7485735.
    View in: PubMed
  131. Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer. Am J Surg. 1995 Nov; 170(5):512-6. PMID: 7485745.
    View in: PubMed
  132. Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg. 1995 Jun; 221(6):706-18; discussion 718-20. PMID: 7794075.
    View in: PubMed
  133. Wanebo HJ, Temple WJ, Popp MB, Constable W, Aron B, Cunningham SL. Preoperative regional therapy for extremity sarcoma. A tricenter update. Cancer. 1995 May 1; 75(9):2299-306. PMID: 7712441.
    View in: PubMed
  134. Shrayer D, Bogaars H, Hearing VJ, Maizel A, Wanebo H. Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine. Cancer Immunol Immunother. 1995 May; 40(5):277-82. PMID: 7600558.
    View in: PubMed
  135. Wanebo HJ, Glicksman AS, Clark JW. Pancreatic cancer symposium: epidemiology, etiology, pathogenesis, and therapy. Pancreas. 1995 Apr; 10(3):217-21. PMID: 7624298.
    View in: PubMed
  136. Vezeridis MP, Wanebo HJ. Sacral resection of posterior pelvic malignancy. Cancer Invest. 1995; 13(4):375-80. PMID: 7627724.
    View in: PubMed
  137. Glicksman AS, Slotman G, Doolittle C, Clark J, Koness J, Coachman N, Posner M, DeRosa E, Wanebo H. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1994 Dec 1; 30(5):1043-50. PMID: 7961010.
    View in: PubMed
  138. Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg. 1994 Oct; 220(4):586-95; discussion 595-7. PMID: 7524455.
    View in: PubMed
  139. Shrayer D, Bogaars H, Gersten D, Hearing V, Maizel A, Wanebo H. Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanoma. J Surg Oncol. 1994 Sep; 57(1):50-6. PMID: 8065154.
    View in: PubMed
  140. Chu QD, Vezeridis MP, Libbey NP, Wanebo HJ. Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum. 1994 Sep; 37(9):950-7. PMID: 8076499.
    View in: PubMed
  141. Coburn M, Teates D, Wanebo HJ. Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg. 1994 Jun; 219(6):587-93; discussion 593-5. PMID: 8203968.
    View in: PubMed
  142. Shrayer D, Koness J, Kouttab N, Bogaars H, Hearing V, Maizel A, Wanebo H. Antitumor effects of polyvalent and monovalent vaccines coupled with interleukin-2 in a metastatic melanoma model. Int J Oncol. 1994 May; 4(5):1121-7. PMID: 21567029.
    View in: PubMed
  143. Vezeridis MP, Wanebo HJ. Pancreatic cancer in 1994: diagnosis and treatment. R I Med. 1994 Apr; 77(4):115-8. PMID: 7516203.
    View in: PubMed
  144. Wanebo HJ, Vezeridis MP. Treatment of gallbladder cancer. Cancer Treat Res. 1994; 69:97-109. PMID: 8031669.
    View in: PubMed
  145. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 1993 Nov; 218(5):583-92. PMID: 8239772.
    View in: PubMed
  146. Chang HR, Wanebo HJ. Engineered vaccines: from overview to a specific application. R I Med. 1993 Nov; 76(11):571-3. PMID: 8312636.
    View in: PubMed
  147. Wanebo HJ, Blackinton D, Kouttab N, Mehta S. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer. Am J Surg. 1993 Oct; 166(4):389-94. PMID: 8214299.
    View in: PubMed
  148. Turk PS, Wanebo HJ. Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer. 1993 Jun 15; 71(12 Suppl):4267-77. PMID: 8508389.
    View in: PubMed
  149. Turk PS, Belliveau JF, Darnowski JW, Weinberg MC, Leenen L, Wanebo HJ. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg. 1993 May; 128(5):533-8; discussion 538-9. PMID: 7683872.
    View in: PubMed
  150. Shrayer D, Koness J, Kouttab N, Bogaars H, Hearing VJ, Gersten DM, Maizel A, Wanebo H. Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL-2 and surgical resection increased survival and tumor control in metastatic melanoma model. J Surg Oncol. 1993 Mar; 52(3):142-9. PMID: 8441268.
    View in: PubMed
  151. Shrayer D, Kouttab N, Maizel A, Wanebo H, Hearing VJ, Gersten DM. Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine. Int J Cancer. 1993 Feb 20; 53(4):696-702. PMID: 8436442.
    View in: PubMed
  152. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 1993 Feb 15; 71(4):1247-53. PMID: 8435801.
    View in: PubMed
  153. Wanebo HJ, Vezeridis MP. Carcinoma of the gallbladder. J Surg Oncol Suppl. 1993; 3:134-9. PMID: 8503972.
    View in: PubMed
  154. Wanebo HJ, Vezeridis MP. Hepatoma. J Surg Oncol Suppl. 1993; 3:40-5. PMID: 8389171.
    View in: PubMed
  155. Yoon M, Chougule P, Dufresne R, Wanebo HJ. Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg. 1992 Dec; 164(6):574-7. PMID: 1463102.
    View in: PubMed
  156. Turk PS, Peters N, Libbey NP, Wanebo HJ. Diagnosis and management of giant intrasacral schwannoma. Cancer. 1992 Dec 1; 70(11):2650-7. PMID: 1423195.
    View in: PubMed
  157. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg. 1992 Dec; 164(6):671-6. PMID: 1463122.
    View in: PubMed
  158. Shrayer D, Gersten DM, Koness J, Maizel A, Wanebo H, Hearing VJ. B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigens. Pigment Cell Res. 1992 Sep; 5(3):107-12. PMID: 1409447.
    View in: PubMed
  159. Wanebo HJ, Koness RJ, Turk PS, Cohen SI. Composite resection of posterior pelvic malignancy. Ann Surg. 1992 Jun; 215(6):685-93; discussion 693-5. PMID: 1632689.
    View in: PubMed
  160. Shrayer D, Koness J, Maizel A, Wanebo H. Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanoma. Melanoma Res. 1992 May; 2(1):47-56. PMID: 1643424.
    View in: PubMed
  161. Kato J, Wanebo H, Calabresi P, Clark JW. Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy. Melanoma Res. 1992 May; 2(1):13-23. PMID: 1322754.
    View in: PubMed
  162. Mehta S, Flanagan P, Blackinton D, Wanebo H. Lymphokine-activated effector cells: modulation of activity by cytokines. Lymphokine Cytokine Res. 1992 Apr; 11(2):73-7. PMID: 1581419.
    View in: PubMed
  163. Yashar J, Weitberg AB, Glicksman AS, Posner MR, Feng W, Wanebo HJ. Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung. Ann Thorac Surg. 1992 Mar; 53(3):445-8. PMID: 1311548.
    View in: PubMed
  164. Cummings FJ, Glicksman AS, Wanebo HJ. Breast cancer management in the nineteen nineties. R I Med. 1992 Jan; 75(1):21-9. PMID: 1543888.
    View in: PubMed
  165. Wanebo HJ, Koness RJ, MacFarlane JK, Eilber FR, Byers RM, Elias EG, Spiro RH. Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck. 1992 Jan-Feb; 14(1):1-7. PMID: 1624288.
    View in: PubMed
  166. Wanebo H, Blackinton D, Weigel T, Turk P, Mehta S. Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alpha. Am J Surg. 1991 Oct; 162(4):384-7. PMID: 1951894.
    View in: PubMed
  167. Wanebo HJ, Vezeridis MP, Llaneras MR. Evaluation of a patient prior to second-look surgery. Semin Surg Oncol. 1991 May-Jun; 7(3):133-7. PMID: 2068445.
    View in: PubMed
  168. Bleday R, Tzanakakis GN, Schwalke MA, Wanebo HJ, Vezeridis MP. Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. J Surg Res. 1990 Sep; 49(3):276-9. PMID: 2395372.
    View in: PubMed
  169. Schwalke MA, Doremus CM, Bleday R, Wanebo HJ, Vezeridis MP. Protein differences in human pancreatic cancer cell lines with diverse metastatic potential. Arch Surg. 1990 Apr; 125(4):469-71. PMID: 2322113.
    View in: PubMed
  170. Wanebo HJ, Temple WJ, Popp MB, Douvill CE, Yablonski M. Combination regional therapy for extremity sarcoma. A tricenter study. Arch Surg. 1990 Mar; 125(3):355-9. PMID: 2407227.
    View in: PubMed
  171. Wanebo HJ, Llaneras M, Martin T, Kaiser D. Prospective monitoring trial for carcinoma of colon and rectum after surgical resection. Surg Gynecol Obstet. 1989 Dec; 169(6):479-87. PMID: 2683153.
    View in: PubMed
  172. Wanebo HJ, Jones T, Pace R, Cantrell R, Levine P. Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck. Am J Surg. 1989 Oct; 158(4):356-60. PMID: 2802041.
    View in: PubMed
  173. Baker DG, Masterson TM, Pace R, Constable WC, Wanebo H. The influence of the surgical wound on local tumor recurrence. Surgery. 1989 Sep; 106(3):525-32. PMID: 2772828.
    View in: PubMed
  174. de Lange EE, Fechner RE, Wanebo HJ. Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology. 1989 Feb; 170(2):323-8. PMID: 2911656.
    View in: PubMed
  175. Wanebo HJ. Tumor necrosis factors. Semin Surg Oncol. 1989; 5(6):402-13. PMID: 2688030.
    View in: PubMed
  176. Wilhelm MC, Wanebo HJ. Technique and guidelines for needle localization biopsy of nonpalpable lesions of the breast. Surg Gynecol Obstet. 1988 Nov; 167(5):439-41. PMID: 3175829.
    View in: PubMed
  177. Lindsey WH, Masterson TM, Llaneras M, Spotnitz WD, Wanebo HJ, Morgan RF. Seroma prevention using fibrin glue during modified radical neck dissection in a rat model. Am J Surg. 1988 Oct; 156(4):310-3. PMID: 2459980.
    View in: PubMed
  178. Wanebo HJ, Cooper PH, Young DV, Harpole DH, Kaiser DL. Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer. 1988 Aug 15; 62(4):831-7. PMID: 3395962.
    View in: PubMed
  179. Pope TL, Fechner RE, Wilhelm MC, Wanebo HJ, de Paredes ES. Lobular carcinoma in situ of the breast: mammographic features. Radiology. 1988 Jul; 168(1):63-6. PMID: 3380984.
    View in: PubMed
  180. Morgan RF, Edgerton MT, Wanebo HJ, Daniel TM, Spotnitz WD, Kron IL. Reconstruction of full thickness chest wall defects. Ann Surg. 1988 Jun; 207(6):707-16. PMID: 3389939.
    View in: PubMed
  181. Wanebo HJ, Riley T, Katz D, Pace RC, Johns ME, Cantrell RW. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell. Cancer. 1988 Feb 1; 61(3):462-74. PMID: 2962730.
    View in: PubMed
  182. Jones RE, Willis S, Innes DJ, Wanebo HJ. Primary gastric lymphoma. Problems in staging and management. Am J Surg. 1988 Jan; 155(1):118-23. PMID: 2449090.
    View in: PubMed
  183. Wallack MK, Bash JA, Leftheriotis E, Seigler H, Bland K, Wanebo H, Balch C, Bartolucci AA. Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate. Arch Surg. 1987 Dec; 122(12):1460-3. PMID: 3689123.
    View in: PubMed
  184. Wanebo HJ, Whitehill R, Gaker D, Wang GJ, Morgan R, Constable W. Composite pelvic resection. An approach to advanced pelvic cancer. Arch Surg. 1987 Dec; 122(12):1401-6. PMID: 3689117.
    View in: PubMed
  185. Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg. 1987 May; 205(5):482-95. PMID: 2437869.
    View in: PubMed
  186. Samson MK, Wasser LP, Borden EC, Wanebo HJ, Creech RH, Phillips M, Baker LH. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol. 1987 Jan; 5(1):86-91. PMID: 3543239.
    View in: PubMed
  187. Fortier GA, Constable WC, Meyers H, Wanebo HJ. Preoperative radiation therapy for rectal cancer. An effective therapy in need of a clinical trial. Arch Surg. 1986 Dec; 121(12):1380-5. PMID: 3789908.
    View in: PubMed
  188. Wilhelm MC, de Paredes ES, Pope T, Wanebo HJ. The changing mammogram. A primary indication for needle localization biopsy. Arch Surg. 1986 Nov; 121(11):1311-4. PMID: 3778204.
    View in: PubMed
  189. Wanebo HJ, Fang WL, Mills AS, Zfass AM. Colorectal cancer. A blueprint for disease control through screening by primary care physicians. Arch Surg. 1986 Nov; 121(11):1347-52. PMID: 3778210.
    View in: PubMed
  190. Wallack MK, McNally K, Michaelides M, Bash J, Bartolucci A, Siegler H, Balch C, Wanebo H. A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). Am Surg. 1986 Mar; 52(3):148-51. PMID: 3513682.
    View in: PubMed
  191. Wallack MK, McNally KR, Leftheriotis E, Seigler H, Balch C, Wanebo H, Bartolucci AA, Bash JA. A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates. Cancer. 1986 Feb 1; 57(3):649-55. PMID: 3943002.
    View in: PubMed
  192. Senofsky GM, Wanebo HJ, Wilhelm MC, Pope TL, Fechner RE, Broaddus W, Kaiser DL. Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer? Cancer. 1986 Feb 1; 57(3):597-602. PMID: 3942996.
    View in: PubMed
  193. Hargett S, Wanebo HJ, Pace R, Katz D, Sando J, Cantrell R. Interleukin-2 production in head and neck cancer patients. Am J Surg. 1985 Oct; 150(4):456-60. PMID: 3876783.
    View in: PubMed
  194. Cooper PH, Wanebo HJ, Hagar RW. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol. 1985 Sep; 121(9):1127-31. PMID: 4037837.
    View in: PubMed
  195. Friedman HI, Cooper PH, Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. 1985 Sep 1; 56(5):1099-105. PMID: 4016700.
    View in: PubMed
  196. Gibby DG, Hanks JB, Wanebo HJ, Kaiser DL, Tegtmeyer CJ, Chandler JG, Jones RS. Bile duct carcinoma. Diagnosis and treatment. Ann Surg. 1985 Aug; 202(2):139-44. PMID: 2990361.
    View in: PubMed
  197. Wanebo HJ, Senofsky GM, Fechner RE, Kaiser D, Lynn S, Paradies J. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg. 1985 Jun; 201(6):667-77. PMID: 4004380.
    View in: PubMed
  198. Wanebo HJ, Cooper PH, Hagar RW. Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg. 1985 Apr; 201(4):499-504. PMID: 3977452.
    View in: PubMed
  199. Wanebo HJ, Harpole D, Teates CD. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk. Cancer. 1985 Mar 15; 55(6):1403-13. PMID: 3971311.
    View in: PubMed
  200. Azizkhan RG, Tegtmeyer CJ, Wanebo HJ. Malignant rectal carcinoid: a sequential multidisciplinary approach for successful treatment of hepatic metastases. Am J Surg. 1985 Feb; 149(2):210-4. PMID: 3970317.
    View in: PubMed
  201. Wanebo HJ, Feldman PS, Wilhelm MC, Covell JL, Binns RL. Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg. 1984 May; 199(5):569-79. PMID: 6721606.
    View in: PubMed
  202. Wanebo HJ, Green S, Marshall D, Pace RC. Antitumor effects of a normal human serum factor (normal human globulin fraction 1) on human tumor cells in vitro. J Natl Cancer Inst. 1984 Mar; 72(3):545-56. PMID: 6199542.
    View in: PubMed
  203. Bernhard MI, Pace RC, Unger SW, Wanebo HJ. Monocyte-mediated antibody-dependent cell-mediated cytotoxicity and spontaneous cytotoxicity in normals and cancer patients as assayed by human erythrocyte lysis. Cancer Res. 1983 Sep; 43(9):4504-10. PMID: 6871879.
    View in: PubMed
  204. Bernhard MI, Wanebo HJ, Helm J, Pace RC, Kaiser DL. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients. Cancer Res. 1983 Apr; 43(4):1932-7. PMID: 6299532.
    View in: PubMed
  205. Wanebo HJ, Andrews W, Kaiser DL. Thyroid cancer: some basic considerations. CA Cancer J Clin. 1983 Mar-Apr; 33(2):87-97. PMID: 6402279.
    View in: PubMed
  206. Wanebo HJ. Cancer trends: the role of CEA in managing colorectal cancer. Va Med. 1983 Feb; 110(2):103-8. PMID: 6342292.
    View in: PubMed
  207. Unger SW, Wanebo HJ. Colonoscopy: an essential monitoring technique after resection of colorectal cancer. Am J Surg. 1983 Jan; 145(1):71-6. PMID: 6849497.
    View in: PubMed
  208. Skinner JR, Wanebo HJ, Betsill WL, Wilhelm MC, Drake CR, Macleod RM. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer. Ann Surg. 1982 Dec; 196(6):636-41. PMID: 7149814.
    View in: PubMed
  209. Whitehill R, Wanebo HJ, Mabie KN, Schildwachter T, Rosenberger R. Reconstruction after the Tikhoff-Linberg procedure. Arch Surg. 1982 Sep; 117(9):1248-9. PMID: 7115074.
    View in: PubMed
  210. Castle WN, Wanebo HJ, Fechner RE. Carcinoma of the gallbladder and cholecystostomy. Arch Surg. 1982 Jul; 117(7):946-8. PMID: 7092546.
    View in: PubMed
  211. Wanebo HJ, Castle WN, Fechner RE. Is carcinoma of the gallbladder a curable lesion? Ann Surg. 1982 May; 195(5):624-31. PMID: 7073360.
    View in: PubMed
  212. Wanebo HJ, Andrews W, Kaiser DL. Thyroid cancer: some basic considerations. Am J Surg. 1981 Oct; 142(4):474-9. PMID: 7283050.
    View in: PubMed
  213. Wanebo HJ, Marcove RC. Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg. 1981 Oct; 194(4):458-71. PMID: 7283507.
    View in: PubMed
  214. Hilal EY, Pinsky CM, Hirshaut Y, Wanebo HJ, Hansen JA, Braun DW, Fortner JG, Oettgen HF. Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum. Cancer. 1981 Jul 15; 48(2):245-51. PMID: 7016302.
    View in: PubMed
  215. Wanebo HJ, Futrell W, Constable W. Multimodality approach to surgical management of locally advanced epidermoid carcinoma of the anorectum. Cancer. 1981 Jun 15; 47(12):2817-26. PMID: 7260873.
    View in: PubMed
  216. Camacho ES, Pinsky CM, Braun DW, Golbey RB, Fortner JG, Wanebo HJ, Oettgen HF. DNCB reactivity and prognosis in 419 patients with malignant melanoma. Cancer. 1981 May 15; 47(10):2446-50. PMID: 7272900.
    View in: PubMed
  217. Wanebo HJ, Woodruff JM, Farr GH, Quan SH. Anorectal melanoma. Cancer. 1981 Apr 1; 47(7):1891-900. PMID: 6164474.
    View in: PubMed
  218. Wanebo HJ. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery. 1981 Mar; 89(3):290-5. PMID: 7466616.
    View in: PubMed
  219. Krown SE, Pinsky CM, Wanebo HJ, Braun DW, Wong PP, Oettgen HF. Immunologic reactivity and prognosis in breast cancer. Cancer. 1980 Oct 15; 46(8):1746-52. PMID: 7427877.
    View in: PubMed
  220. Wanebo HJ, Rao B, Attiyeh F, Pinsky C, Middleman P, Stearns M. Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters. Cancer. 1980 Mar 15; 45(5 Suppl):1254-63. PMID: 7357518.
    View in: PubMed
  221. Fukuda M, Wanebo HJ, Tsuei L, Ashikari R, Sarkar NH. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses. J Natl Cancer Inst. 1980 Mar; 64(3):431-7. PMID: 6243720.
    View in: PubMed
  222. Wanebo HJ. Immunobiology of head and neck cancer: basic concepts. Head Neck Surg. 1979 Sep-Oct; 2(1):42-55. PMID: 400659.
    View in: PubMed
  223. Wanebo HJ, Fukuda M, Tsuei L, Sarkar N, Ashikari H. The leukocyte migration inhibition response to certain breast cancer-related antigens (MCF-7 and MuMTV): their potential as discriminants. Surgery. 1979 Aug; 86(2):275-83. PMID: 462374.
    View in: PubMed
  224. Wanebo HJ. Immunologic testing as a guide to cancer management. Surg Clin North Am. 1979 Apr; 59(2):323-47. PMID: 375447.
    View in: PubMed
  225. Unger SW, Bernhard MI, Pace R, Wanebo HJ. Alterations of monocyte function in neoplastic diseases. Surg Forum. 1979; 30:142-4. PMID: 538578.
    View in: PubMed
  226. Krown SE, Hilal EY, Pinsky CM, Hirshaut Y, Wanebo HJ, Hansen JA, Huvos AG, Oettgen HF. Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma. Cancer. 1978 Dec; 42(6):2648-60. PMID: 728866.
    View in: PubMed
  227. Wanebo HJ, Hilal EY, Pinsky CM, Strong EW, Mike V, Hirshaut Y, Oettgen HF. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report. Cancer Treat Rep. 1978 Nov; 62(11):1663-9. PMID: 365322.
    View in: PubMed
  228. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978 Aug 31; 299(9):448-51. PMID: 683276.
    View in: PubMed
  229. Attiyeh FF, Wanebo HJ, Stearns MW. Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum. 1978 Apr; 21(3):160-2. PMID: 648298.
    View in: PubMed
  230. Wanebo HJ, Pinsky CM, Beattie EJ, Oettgen HF. Immunocompetence testing in patients with one of the four common operable cancers--a review. Clin Bull. 1978; 8(1):15-22. PMID: 668106.
    View in: PubMed
  231. Wanebo HJ, Hilal EY, Strong EW, Pinsky CM, Mike V, Oettgen HF. Adjuvant trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report. Recent Results Cancer Res. 1978; 68:324-33. PMID: 379937.
    View in: PubMed
  232. Wanebo HJ, Semoglou C, Attiyeh F, Stearns MJ. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg. 1978 Jan; 135(1):81-5. PMID: 623377.
    View in: PubMed
  233. Wanebo HJ, Thaler HT, Hansen JA, Rosen PP, Robbins GF, Urban JA, Oettgen HF, Good RA. Immunologic reactivity in patients with primary operable breast cancer. Cancer. 1978 Jan; 41(1):84-94. PMID: 304759.
    View in: PubMed
  234. Hilal EY, Wanebo HJ, Pinsky CM, Middleman P, Strong EW, Oettgen HF. Immunologic evaluation and prognosis in patients with head and neck cancer. Am J Surg. 1977 Oct; 134(4):468-73. PMID: 303057.
    View in: PubMed
  235. Khafagy M, Wanebo HJ, Alfieri A, Hahn EW. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A). AJR Am J Roentgenol. 1977 Jun; 128(6):1027-9. PMID: 414534.
    View in: PubMed
  236. Rao B, Wanebo HJ, Pinsky C, Stearns M, Oettgen HF. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. Surg Gynecol Obstet. 1977 May; 144(5):677-81. PMID: 850850.
    View in: PubMed
  237. Rao B, Wanebo HJ, Ochoa M, Lewis JL, Oettgen HF. Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. Cancer. 1977 Feb; 39(2):514-26. PMID: 837334.
    View in: PubMed
  238. Wanebo HJ, Martini N, Melamed MR, Hilaris B, Beattie EJ. Pleural mesothelioma. Cancer. 1976 Dec; 38(6):2481-8. PMID: 826313.
    View in: PubMed
  239. Wanebo HJ, Rao B, Miyazawa N, Martini N, Middleman MP, Oettgen HF, Beattie EJ. Immune reactivity in primary carcinoma of the lung and its relation to prognosis. J Thorac Cardiovasc Surg. 1976 Sep; 72(3):339-50. PMID: 183063.
    View in: PubMed
  240. Pinsky CM, Hirshaut Y, Wanebo HJ, Fortner JG, Miké V, Schottenfeld D, Oettgen HF. Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma. Ann N Y Acad Sci. 1976; 277(00):187-94. PMID: 1069548.
    View in: PubMed
  241. Wanebo HJ, Jun MY, Strong EW, Oettgen H. T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg. 1975 Oct; 130(4):445-51. PMID: 1101724.
    View in: PubMed
  242. Wanebo HJ, Fortner JG, Woodruff J, MacLean B, Binkowski E. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg. 1975 Sep; 182(3):302-15. PMID: 1164058.
    View in: PubMed
  243. Wanebo HJ, Grimes OF. Cancer of the bile duct: the occult malignancy. Am J Surg. 1975 Aug; 130(2):262-8. PMID: 1155739.
    View in: PubMed
  244. Wanebo HJ, Woodruff J, Fortner JG. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer. 1975 Mar; 35(3):666-76. PMID: 1111935.
    View in: PubMed
  245. Tsakraklides V, Wanebo HJ, Sternberg SS, Stearns M, Good RA. Prognostic evaluation of regional lymph node morphology colorectal cancer. Am J Surg. 1975 Feb; 129(2):174-80. PMID: 1119677.
    View in: PubMed
  246. Arlen M, Wanebo H, Guerra O, Higinbotham N, Huvos A, Miller T. Osseous metastasis: its relationship to primary carcinoma of the head and neck. Am J Surg. 1974 Oct; 128(4):568-72. PMID: 4423265.
    View in: PubMed
  247. Lundy J, Wanebo H, Pinsky C, Strong E, Oettgen H. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck. Am J Surg. 1974 Oct; 128(4):530-3. PMID: 4429642.
    View in: PubMed
  248. Wanebo HJ, Huvos AG, Urban JA. Proceedings: Treatment of minimal breast cancer. Cancer. 1974 Feb; 33(2):349-57. PMID: 4360055.
    View in: PubMed
  249. Wanebo HJ, Quan SH. Failures of electrocoagulation of primary carcinoma of the rectum. Surg Gynecol Obstet. 1974 Feb; 138(2):174-6. PMID: 4810854.
    View in: PubMed
  250. Wanebo HJ, Shah J, Knapper W, Hajdu S, Booher R. Reappraisal of surgical management of sarcoma of the buttock. Cancer. 1973 Jan; 31(1):97-104. PMID: 4345612.
    View in: PubMed
Harold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department